Consumer Analyst Group of New York Conference 2026 February 17, 2026 4:00 PM ESTCompany ParticipantsJames Zallie - ...

Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1 ...

Krystal is leveraging a validated, redosable platform with high margins, profitability, and multiple blockbuster catalysts in CF and NK. Read why KRYS is a Buy.

EpitogenX and Attomarker sign co-development agreement to advance precision immunology diagnostics in multiple diseases ...

Ticketek Entertainment Group has appointed Brad Turcotte as senior vice president of country at TEG Live.The ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...

Q VYJUVEK revenue and $730.3 million since U.S. launchFDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast ...

Spotify Technology (SPOT) stock continues to surge Tuesday morning after the music streaming platform reported fourth quarter ...

The campaign exploits an Office vulnerability to deliver the modular XWorm RAT, chaining HTA, PowerShell, and in-memory .NET execution to sidestep detection and expand post-compromise control.

PDE6A-associated RP, a rare form of inherited retinal disease (IRD), is characterized by nyctalopia, visual field defects, and significant loss of visual acuity (VA). The disease primarily affects the ...

The CCPA holds that marketplace platforms cannot evade accountability by claiming intermediary status when consumer safety is ...

As climate change extends mosquito habitats and vector-borne diseases remain a critical concern, industry analysis suggests that DEET production capacity and supply chain resilience are receiving ...